The addition of nab-paclitaxel to gemcitabine and cisplatin did not improve survival in advanced biliary tract cancer.

inoperable biliary tract cancer," Shroff said. "Our research also indicates that the three-drug regimen may increase the toxicity of the treatment." Shroff noted that the three-drug regimen might ...